Cargando…

In Vitro Efficacy of Dalbavancin as a Long-Acting Anti-Biofilm Agent Loaded in Bone Cement

Based on previous studies by our group in which we demonstrated that dalbavancin loaded in bone cement had good elution capacity for the treatment of biofilm-related periprosthetic infections, we now assess the anti-biofilm activity of dalbavancin and compare it with that of vancomycin over a 3-mont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sánchez-Somolinos, Mar, Díaz-Navarro, Marta, Benjumea, Antonio, Matas, José, Vaquero, Javier, Muñoz, Patricia, Sanz-Ruíz, Pablo, Guembe, María
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525811/ https://www.ncbi.nlm.nih.gov/pubmed/37760741 http://dx.doi.org/10.3390/antibiotics12091445

Ejemplares similares

Determination of the Elution Capacity of Dalbavancin in Bone Cements: New Alternative for the Treatment of Biofilm-Related Peri-Prosthetic Joint Infections Based on an In Vitro Study
por: Sánchez-Somolinos, Mar, et al.
Publicado: (2022)

Effect of Tranexamic Acid against Staphylococcus spp. and Cutibacterium acnes Associated with Peri-Implant Infection: Results from an In Vitro Study
por: Benjumea, Antonio, et al.
Publicado: (2022)

Tranexamic Acid in Combination With Vancomycin or Gentamicin Has a Synergistic Effect Against Staphylococci
por: Benjumea, Antonio, et al.
Publicado: (2022)

A Dalbavancin Lock Solution Can Reduce Enterococcal Biofilms After Freezing
por: Díaz-Navarro, Marta, et al.
Publicado: (2022)

Correction to: A Dalbavancin Lock Solution Can Reduce Enterococcal Biofilms After Freezing
por: Díaz-Navarro, Marta, et al.
Publicado: (2022)

An In Vitro Study to Assess the Best Strategy for the Chemical Debridement of Periprosthetic Joint Infection
por: Márquez-Gómez, Miguel, et al.
Publicado: (2023)

Biofilm-Related Infections in Gram-Positive Bacteria and the Potential Role of the Long-Acting Agent Dalbavancin
por: Oliva, Alessandra, et al.
Publicado: (2021)

Revision TKA with a condylar constrained prosthesis using metaphyseal and surface cementation: a minimum 6-year follow-up analysis
por: Sanz-Ruiz, Pablo, et al.
Publicado: (2015)

Effect of Dalbavancin on Staphylococcal Biofilms When Administered Alone or in Combination With Biofilm-Detaching Compounds
por: Žiemytė, Miglë, et al.
Publicado: (2020)

Dalbavancin
por: Barberán, José, et al.
Publicado: (2021)

Role of Extracellular DNA in Dalbavancin Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms in Patients with Skin and Soft Tissue Infections
por: Sivori, Francesca, et al.
Publicado: (2022)

In vitro additive effects of dalbavancin and rifampicin against biofilm of Staphylococcus aureus
por: Jacob, Benjamin, et al.
Publicado: (2021)

Risk assessment of antibiotic resistance development by antibiotic-loaded bone cements: is it a clinical concern?
por: Berberich, Christof, et al.
Publicado: (2019)

Dalbavancin: a novel antimicrobial
por: Chen, A Y, et al.
Publicado: (2007)

Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE)
por: Knafl, D., et al.
Publicado: (2016)

Comparative Analysis of Dalbavancin versus Other Antimicrobial Options for Gram-Positive Cocci Infections: Effectiveness, Hospital Stay and Mortality
por: de Pablo-Miró, Mar, et al.
Publicado: (2021)

A Dalbavancin for Successful Treatment of Infective Endocarditis Caused by Enterococcus faecalis
por: Teigell-Muñoz, Francisco Javier, et al.
Publicado: (2023)

Long-term outcomes of one single-design varus valgus constrained versus one single-design rotating hinge in revision knee arthroplasty after over 10-year follow-up
por: Sanz-Ruiz, Pablo, et al.
Publicado: (2022)

Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety
por: Ruiz-Sancho, Andrés, et al.
Publicado: (2023)

In vitro study to assess modulation of Candida biofilm by Escherichia coli from vaginal strains
por: Díaz-Navarro, Marta, et al.
Publicado: (2023)

Patients at a high risk of PJI: Can we reduce the incidence of infection using dual antibiotic-loaded bone cement?
por: Berberich, Christof, et al.
Publicado: (2022)

Biarticular total femur spacer for massive femoral bone loss: the mobile solution for a big problem
por: Sanz-Ruiz, Pablo, et al.
Publicado: (2017)

Determination of the ability of matrix-assisted laser desorption ionization time-of-flight mass spectrometry to identify high-biofilm-producing strains
por: Rodríguez-Temporal, David, et al.
Publicado: (2023)

Dalbavancin in clinical practice in Spain: a 2 year retrospective study
por: Morata, Laura, et al.
Publicado: (2022)

267 Dalbavancin for the treatment of Streptococcal Skin Infections
por: Puttagunta, Sailaja, et al.
Publicado: (2014)

Successful Treatment of Diabetic Foot Osteomyelitis with Dalbavancin
por: Loupa, Chariclia V., et al.
Publicado: (2020)

Dalbavancin: novel candidate for COVID-19 treatment
por: Hoffmann, Markus, et al.
Publicado: (2021)

Evaluating the Use of Dalbavancin for Off-Label Indications
por: Taylor, Katherine, et al.
Publicado: (2022)

Global trends of dalbavancin: A bibliometric analysis
por: Monteagudo‐Martínez, Nuria, et al.
Publicado: (2022)

The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa
por: Molinelli, Elisa, et al.
Publicado: (2022)

Dalbavancin for Staphylococcus aureus Bacteremia: Are We There Yet?
por: Mahatanan, Rattanaporn, et al.
Publicado: (2023)

2902. Dalbavancin Use in Bone and Joint Infections
por: Sanikommu, Srivani, et al.
Publicado: (2023)

2764. Experience with dalbavancin in a pediatric hospital
por: Leon, Maria Deza, et al.
Publicado: (2023)

DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci
por: Hidalgo-Tenorio, Carmen, et al.
Publicado: (2019)

The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia
por: Bouza, Emilio, et al.
Publicado: (2014)

Dalbavancin Population Pharmacokinetic Modeling and Target Attainment Analysis
por: Carrothers, Timothy J., et al.
Publicado: (2019)

1268. Dalbavancin for the Treatment of Infections due to Staphylococcus aureus
por: Streifel, Amber C, et al.
Publicado: (2020)

122. Dalbavancin Use in Patients with Substance Use Disorders
por: Streifel, Amber C, et al.
Publicado: (2020)

Use of dalbavancin in infective endocarditis: a case series
por: Guleri, Achyut, et al.
Publicado: (2021)

614. Evaluating the Use of Dalbavancin for Off-Label Indications
por: Taylor, Katherine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oofamas39q6a2o6bc7g8q8u99u